Management Board meeting: 7 October 2010

• Date:
  Ceturtdiena, 7 Oktobris 2010, Visu dienu
• Vieta:
  European Medicines Agency, Amsterdam, the Netherlands

The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.

Documents

Minutes of the 68th meeting of the Management Board: 7 October 2010

Adopted Reference Number: EMA/MB/628133/2010

Agenda for the 68th meeting of the Management Board

Reference Number: EMA/MB/398075/2010

Minutes of the 67th meeting of the Management Board: 10 June 2010

Adopted Reference Number: EMA/MB/404038/2010

European Medicines Agency mid-year report 2010 from the Executive Director (January - June 2010)

Reference Number: EMA/MB/511982/2010

Procedure for the appointment of the Executive Director

Reference Number: EMA/MB/400828/2009

Appointment of an Acting Executive Director, Management Board meeting 7 October 2010

Reference Number: EMA/MB/578243/2010

Revision of the Financial Regulation and its Implementing Rules

Reference Number: EMA/MB/528780/2010

Financial regulation applicable to the budget of the European Medicines Agency

Reference Number: EMA/MB/789566/2013 Legal effective date: 01/01/2014

Rules for the implementation of the financial regulation applicable to the budget of the European Medicines Agency

Reference Number: EMA/MB/99010/2014 Rev. 1 Legal effective date: 01/01/2014

Transfers of appropriations in the budget 2010 in accordance with Article 23 (2) of the Financial Regulation

Reference Number: EMA/MB/603657/2010

Amendment to the Agency’s internal control standard on sensitive functions

Reference Number: EMA/MB/568706/2010

Preparation for written procedure on adoption of the Agency’s policy on protecting the dignity of the person and preventing any form of psychological or sexual harassment

Reference Number: EMA/MB/575364/2010

Amendments to Management Board implementing rules on the Agency’s fees in relation to extensions of marketing authorisation, Type II variations, annual fees, variations to plasma master files and vaccine antigen master f...

Reference Number: EMA/MB/818152/2009

Sponsoring of Patients’ Organisations by pharmaceutical industry – proposed actions

Reference Number: EMA/MB/531926/2010

Third report on the progress of the interaction with Patients' and Consumers' Organisations during 2009: Management Board meeting 7 October 2010

Reference Number: EMA/MB/599720/2010

2009 EudraVigilance-Human Status Report

Reference Number: EMA/MB/599720/2010

Outcome of Management Board written procedures

Reference Number: EMA/MB/535239/2010

Summary of transfers of appropriations in the budget 2010 - Management Board meeting: 7 October 2010

Reference Number: EMA/MB/528844/2010